Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Japan
Biotech
Kissei pays Viridian $70M to challenge Amgen for Japanese market
Kissei is paying $70 million upfront for Japanese rights to two thyroid eye disease assets, establishing the company as a potential rival to Amgen.
Nick Paul Taylor
Jul 30, 2025 4:50am
AN Venture Partners raises $200M to boost Japan biotech industry
Jul 2, 2025 11:45am
FDA moves to block Olympus endoscope imports
Jun 25, 2025 12:05pm
Astellas offers lab space to help Japanese biotechs 'go global'
Jun 13, 2025 4:41am
Kaken pens $180M pact for Alumis' lead TYK2 inhibitor in Japan
Mar 25, 2025 6:55am
Eisai pays $46M for Japan rights to Newron's schizophrenia med
Dec 13, 2024 8:37am
